Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360° London', April 25-26, 2012
(firmenpresse) - LONDON -- (Marketwire) -- 03/30/12 --
, the medtech industry's leading provider of strategic partnership and investment conferences, will host the investor conference on , at the .
Building on the success of past IN3 events in Paris, Rome and Brussels, the conference will feature presentations by approximately 25 early-, mid- and late-stage start-up companies from around the world seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels and networking sessions with industry thought leaders discussing pressing issues facing the global device industry in 2012 and beyond.
Additional participating speakers confirmed to date include: ; ; ; ; ; and .
Panel topics will include: Corporate Buy-Side Perspective: What Are Buyers Looking for in 2012?; Business Challenges Facing Wireless Health Ventures; and Raising Venture Capital in Europe: The Best of Times or the Worst of Times? In addition, the two-day program will feature profile presentations by the following healthcare investment firms, among others: , , , , , , and . Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.
This two-day special event will benefit a wide variety of participants in the global medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact at 949-797-7142, or email .
IN3 Medical Device 360° London will be held at the . Event co-sponsors to date include , , , , and . Visit for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360° events in 2012, in and ; visit for more information.
Presenting companies to date include: Anethon, CellCoTec, Cortical Dynamics Ltd., Endomagnetics Ltd., Endomagnetics, Enox BioPharma, Implandata Ophthalmic Products GmbH, N8 Medical Inc., NUUBO, QSTREAM VASCULAR, Replication Medical Inc., Sapiens Steering Brain Stimulation, Soft Tissue Regeneration Inc., Specialty Scanners plc, Vantix Ltd., and Vascular Flow Technologies Ltd.
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.03.2012 - 15:23 Uhr
Sprache: Deutsch
News-ID 130490
Anzahl Zeichen: 0
contact information:
Town:
LONDON
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 269 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360° London', April 25-26, 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Elsevier Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
